Frederic Taieb

Dr. Frederic Taieb


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2006 in Science
Verified
Journal Article
Closed access
PDF file
Jean-Philippe NougayredeJean-Philippe Nougayrede
Jean-Philippe Nougayrede
SHStefan Homburg
Stefan Homburg
FTFrederic Taieb
Frederic Taieb
MBMichèlE Boury
MichèlE Boury
EBElzbieta Brzuszkiewicz
Elzbieta Brzuszkiewicz
Eric OswaldEric Oswald
Eric Oswald
Transient infection of eukaryotic cells with commensal and extraintestinal pathogenic Escherichia coli of phylogenetic group B2 blocks mitosis and induces megalocytosis. This trait is linked to a widely spread genomic island that encodes giant modular nonribosomal peptide and polyketide synthases. Contact with E. coli expressing this gene cluster causes DNA double-strand breaks and activation of the DNA damage checkpoint pathway, leading to cell cycle arrest and eventually to cell death. Discovery of hybrid peptide-polyketide genotoxins in E. coli will change our view on pathogenesis and commensalism and open new biotechnological applications.

2 May 2018 in mBio
Verified
Journal Article
Open access
PDF file
NBNadège Bossuet-Greif
Nadège Bossuet-Greif
JVJulien Vignard
Julien Vignard
FTFrederic Taieb
Frederic Taieb
Gladys MireyGladys Mirey
Gladys Mirey
DDDamien Dubois
Damien Dubois
Jean-Philippe NougayredeJean-Philippe Nougayrede
Jean-Philippe Nougayrede
Colibactins are hybrid polyketide-nonribosomal peptides produced by Escherichia coli , Klebsiella pneumoniae , and other Enterobacteriaceae harboring the pks genomic island. These genotoxic metabolites are produced by pks -encoded peptide-polyketide synthases as inactive prodrugs called precolibactins, which are then converted to colibactins by deacylation for DNA-damaging effects. Colibactins are bona fide virulence factors and are suspected of promoting colorectal carcinogenesis when produced by intestinal E. coli . Natural active colibactins have not been isolated, and how they induce DNA damage in the eukaryotic host cell is poorly characterized. Here, we show that DNA strands are cross-linked covalently when exposed to enterobacteria producing colibactins. DNA cross-linking is abrogated in a clbP mutant unable to deacetylate precolibactins or by adding the colibactin self-resistance protein ClbS, confirming the involvement of the mature forms of colibactins. A similar DNA-damaging mechanism is observed in cellulo , where interstrand cross-links are detected in the genomic DNA of cultured human cells exposed to colibactin-producing bacteria. The intoxicated cells exhibit replication stress, activation of ataxia-telangiectasia and Rad3-related kinase (ATR), and recruitment of the DNA cross-link repair Fanconi anemia protein D2 (FANCD2) protein. In contrast, inhibition of ATR or knockdown of FANCD2 reduces the survival of cells exposed to colibactin-producing bacteria. These findings demonstrate that DNA interstrand cross-linking is the critical mechanism of colibactin-induced DNA damage in infected cells. IMPORTANCE Colorectal cancer is the third-most-common cause of cancer death. In addition to known risk factors such as high-fat diets and alcohol consumption, genotoxic intestinal Escherichia coli bacteria producing colibactin are proposed to play a role in colon cancer development. Here, by using transient infections with genotoxic E. coli , we showed that colibactins directly generate DNA cross-links in cellulo . Such lesions are converted into double-strand breaks during the repair response. DNA cross-links, akin to those induced by metabolites of alcohol and high-fat diets and by widely used anticancer drugs, are both severely mutagenic and profoundly cytotoxic lesions. This finding of a direct induction of DNA cross-links by a bacterium should facilitate delineating the role of E. coli in colon cancer and engineering new anticancer agents.

1 March 2005 in Trends in Microbiology
Verified
Journal Article
Closed access
Jean-Philippe NougayredeJean-Philippe Nougayrede
Jean-Philippe Nougayrede
FTFrederic Taieb
Frederic Taieb
JRJean De Rycke
Jean De Rycke
Eric OswaldEric Oswald
Eric Oswald

1 April 2000 in Current Biology
Verified
Journal Article
Closed access
SGStefan D Gross
Stefan D Gross
MSMarkus S Schwab
Markus S Schwab
FTFrederic Taieb
Frederic Taieb
ALAndrea L Lewellyn
Andrea L Lewellyn
YQYue-Wei Qian
Yue-Wei Qian
JMJames L Maller
James L Maller

1 February 2005 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
Eric OswaldEric Oswald
Eric Oswald
Jean-Philippe NougayredeJean-Philippe Nougayrede
Jean-Philippe Nougayrede
FTFrederic Taieb
Frederic Taieb
MSMotoyuki Sugai
Motoyuki Sugai

1 June 2001 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
YQYue-Wei Qian
Yue-Wei Qian
EEEleanor Erikson
Eleanor Erikson
FTFrederic Taieb
Frederic Taieb
JMJames L. Maller
James L. Maller
In the Xenopus oocyte system mitogen treatment triggers the G2/M transition by transiently inhibiting the cAMP-dependent protein kinase (PKA); subsequently, other signal transduction pathways are activated, including the mitogen-activated protein kinase (MAPK) and polo-like kinase pathways. To study the interactions between these pathways, we have utilized a cell-free oocyte extract that carries out the signaling events of oocyte maturation after addition of the heat-stable inhibitor of PKA, PKI. PKI stimulated the synthesis of Mos and activation of both the MAPK pathway and the Plx1/Cdc25C/cyclin B-Cdc2 pathway. Activation of the MAPK pathway alone by glutathione S-transferase (GST)-Mos did not lead to activation of Plx1 or cyclin B-Cdc2. Inhibition of the MAPK pathway in the extract by the MEK1 inhibitor U0126 delayed, but did not prevent, activation of the Plx1 pathway, and inhibition of Mos synthesis by cycloheximide had a similar effect, suggesting that MAPK activation is the only relevant function of Mos. Immunodepletion of Plx1 completely inhibited activation of Cdc25C and cyclin B-Cdc2 by PKI, indicating that Plx1 is necessary for Cdc25C activation. In extracts containing fully activated Plx1 and Cdc25C, inhibition of cyclin B-Cdc2 by p21Cip1had no significant effect on either the phosphorylation of Cdc25C or the activity of Plx1. These results demonstrate that maintenance of Plx1 and Cdc25C activity during mitosis does not require cyclin B-Cdc2 activity.